Oppenheimer analyst Mark Breidenbach downgrades Forma Therapeutics Hldgs (NASDAQ:FMTX) from Outperform to Perform.
Tyson Foods Expects FY24 Revenue To Be Flat Y/Y, Adj. Operating Income $1.0B-$1.5B
Total Company
We anticipate total company adjusted operating income of $1.0 billion to $1.5 billion for fiscal 2024.
Revenue
We expect sales to be relatively flat in fiscal 2024 as compared to fiscal 2023.
Capital